Stocks Walgreens Boots Alliance Inc

More

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks were lower this morning, after Wednesday's severe slide sent Wall Street to its lowest level since late September.

  • Traders work on the floor of the New York Stock Exchange.

    Global slowdown taking toll on U.S. companies.

  • Investor thinking

    Jim Cramer helps investors manage market anxiety with his tips to making money in a world of fear.

  • A trader works on the floor of the New York Stock Exchange.

    U.S. stock index futures indicated a sharply lower open on Thursday after trading in China was suspended for the second time in a week.

  • Trader on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Walgreens, which offered to buy Rite Aid for $9.4 billion in October, said the deal was progressing as planned. Walgreens said it now expected an adjusted profit of $4.30- $4.55 per share for the year ending August, compared with $4.25- $4.55 it had forecast earlier. The net income attributable to Walgreens rose to $1.11 billion, or $1.01 per share, in the first...

  • Jan 7- Drugstore operator Walgreens Boots Alliance Inc, which has offered to buy smaller rival Rite Aid Corp, reported lower-than-expected quarterly net sales. Net income attributable to Walgreens Boots rose to $1.11 billion, or $1.01 per share, in the first quarter ended Nov. 30, from $850 million, or 89 cents per share, a year earlier. Net sales rose 48.5 percent to...

  • Couple riding roller coaster, woman screaming

    Stocks are scratching around for an excuse to move higher, but bears may keep the pressure on ahead of Friday's jobs report.

  • The headquarters of Valeant Pharmaceuticals International in Laval, Quebec.

    Valeant Pharmaceuticals will appoint an interim chief CEO to replace Michael Pearson who is hospitalized, sending shares down 7 percent on Tuesday.

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks opened sharply lower in a global equities sell off that started with a report showing a tenth month of decline in Chinese manufacturing.

  • Handshake M&A mergers

    2015 was a record year for mergers. Here's what the research reveals about how 2016 will compare, says Matt Porzio.

  • NEW YORK, Dec 28- Valeant Pharmaceuticals International Inc on Monday said a group of company executives will immediately take over for its chief executive officer until he returns from medical leave, news that sent its shares tumbling 10 percent. Valeant said its board has created an "office of the Chief Executive Officer," which will include General Counsel...

  • Dec 28- Valeant Pharmaceuticals International Inc on Monday said a group of company executives will immediately take over for its chief executive officer until he returns from medical leave, sending shares tumbling 10 percent. Valeant said its board has created an "office of the Chief Executive Officer," which will include General Counsel Robert Chai-Onn,...

  • Dec 28- Valeant Pharmaceuticals International Inc said a group of company executives will take over in an interim capacity, until CEO Michael Pearson returns from medical leave. Valeant's board has created an "office of the Chief Executive Officer", which will include general counsel Robert Chai-Onn, company group chairman Ari Kellen, and chief financial...

  • China investor stock prices

    Here are the top 10 business stories of the year, in descending order. NBCNews reports.

  • NEW YORK, Dec 23- The recent pact between Valeant Pharmaceuticals International and Walgreens Boots Alliance may salvage the drugmaker's relationships with physicians, but is unlikely to fully restore Valeant's previous revenue growth from high-priced, branded drugs, according to doctors and investors. Under the deal announced last week, Walgreen's will...

  • Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Futures point to a moderately lower open Tuesday, leaving the Dow and S&P 500 with little time to erase their 2015 deficits.

  • Dec 18- As Turing Pharmaceuticals Chief Executive Officer Martin Shkreli contends with charges of securities fraud, major U.S. pharmacies are moving to assure patients of continued access to the company's key drug, Daraprim. CVS Health Corp, the No. 2 U.S. drug benefit manager, told Reuters on Thursday it can provide an alternative to Daraprim that is compounded...

  • Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.